Literature DB >> 27087878

Embolosclerotherapy by the Transvenous Approach for Lower Extremity Arteriovenous Malformation in Cowden Syndrome: A Case Report.

Akiyuki Matsuhisa1, Mitsuhiro Kishino2, Masashi Nakadate2, Toshifumi Kudo3, Yoshinori Inoue3, Ukihide Tateishi2.   

Abstract

A 69-year-old female with Cowden syndrome presented with pain at rest in the right leg. Arteriovenous malformations (AVMs) of the right lower extremity were detected by computed tomography and magnetic resonance imaging. Angiography indicated arteriolovenous fistulae, which were initially treated using a transarterial approach with minimal therapeutic effect. In contrast, excellent outcomes were achieved with a transvenous approach using coil embolization and liquid sclerotherapy for the venous component of the nidus. At 15 months after embolosclerotherapy, no angiographic evidence of AVM recurrence was noted. Embolosclerotherapy by the transvenous approach for AVM in Cowden syndrome was a useful therapeutic strategy for arteriolovenous fistulae.

Entities:  

Keywords:  Cowden syndrome; arteriovenous malformation; embolosclerotherapy

Year:  2016        PMID: 27087878      PMCID: PMC4807220          DOI: 10.3400/avd.cr.15-00058

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  9 in total

1.  Endovascular treatment combined with emboloscleorotherapy for pelvic arteriovenous malformations.

Authors:  Young Soo Do; Young-Wook Kim; Kwang Bo Park; Dong-Ik Kim; Hong Suk Park; Sung Ki Cho; Sung Wook Shin; Yang Jin Park
Journal:  J Vasc Surg       Date:  2011-11-01       Impact factor: 4.268

Review 2.  Familial thyroid cancer.

Authors:  O Alsanea; O H Clark
Journal:  Curr Opin Oncol       Date:  2001-01       Impact factor: 3.645

3.  Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification.

Authors:  Sung Ki Cho; Young Soo Do; Sung Wook Shin; Dong-Ik Kim; Young Wook Kim; Kwang Bo Park; Eun Jin Kim; Hyun Joo Ahn; Sung Wook Choo; In-Wook Choo
Journal:  J Endovasc Ther       Date:  2006-08       Impact factor: 3.487

4.  Transcatheter embolization of arteriovenous malformations in Cowden disease.

Authors:  N Takaya; T Iwase; A Maehara; S Nishiyama; S Nakanishi; D Yamana; R Takei; T Kokubo; H Kohtake; S Furui; H Tomoyasu; A Seki
Journal:  Jpn Circ J       Date:  1999-04

5.  Arteriovenous malformations in Cowden syndrome.

Authors:  M M Turnbull; V Humeniuk; B Stein; G K Suthers
Journal:  J Med Genet       Date:  2005-08       Impact factor: 6.318

6.  Intestinal bleeding from arteriovenous malformations of the small bowel in a patient with Cowden syndrome: report of a case.

Authors:  Yoshifumi Nakayama; Jun Segawa; Kazufumi Sujita; Noritaka Minagawa; Takayuki Torigoe; Masanori Hisaoka; Koji Yamaguchi
Journal:  Surg Today       Date:  2012-12-18       Impact factor: 2.549

7.  A proposed angiographic classification of intracranial arteriovenous fistulae and malformations.

Authors:  E Houdart; Y P Gobin; A Casasco; A Aymard; D Herbreteau; J J Merland
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

8.  Embolization therapy of congenital arteriovenous malformations: use of alternate approaches.

Authors:  A S Gomes
Journal:  Radiology       Date:  1994-01       Impact factor: 11.105

Review 9.  Polidocanol for endovenous microfoam sclerosant therapy.

Authors:  David M Eckmann
Journal:  Expert Opin Investig Drugs       Date:  2009-12       Impact factor: 6.206

  9 in total
  2 in total

1.  Temporal Evolution and Management of Fast Flow Vascular Anomalies in PTEN Hamartoma Tumor Syndrome.

Authors:  Sheena Pimpalwar; Raphael Yoo; Alex Chau; Daniel Ashton; Judith Margolin; Ionela Iacobas
Journal:  Int J Angiol       Date:  2018-06-28

2.  Image-guided percutaneous sclerotherapy of venous malformations of the head and neck: Clinical and MR-based volumetric mid-term outcome.

Authors:  Dominik F Vollherbst; Philipp Gebhart; Steffen Kargus; Astrid Burger; Reinald Kühle; Patrick Günther; Jürgen Hoffmann; Martin Bendszus; Markus A Möhlenbruch
Journal:  PLoS One       Date:  2020-10-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.